Fecal transplant for sepsis outcomes in the ICU
Part of Infections clinical trials.
This trial tests if a fecal microbiota transplant (FMT) can improve survival and recovery in ICU patients with sepsis. FMT involves transferring healthy donor bacteria into your gut to help fight severe infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have sepsis with a rise in your SOFA score (a measure of organ failure) of 2 or more points.
- You must not have active major gut bleeding, a hole in your intestine, or other severe gut damage.
- You must not need a feeding tube because of severe diarrhea or blockages.
- You must not have had recent abdominal surgery (within the past 2 weeks) or have a planned surgery soon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal microbiota transplant (FMT)—transferring healthy gut bacteria from a donor to your digestive system—can help critically ill patients tolerate food and nutrition delivered through a feeding tube. The goal is to restore gut function and improve recovery in the ICU.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
This study tests if transferring healthy gut bacteria (fecal microbiota transplant) can help people with acute lung injury caused by sepsis. It aims to reduce inflammation and improve breathing.
This study tests whether a treatment called fecal microbiota transplantation (FMT) can help clear stubborn lung infections (MDRO) in people who are in the ICU on a ventilator. The goal is to see if FMT can improve recovery and reduce the risk of further organ problems.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This study looks at changes in the microbiome (gut bacteria) in adults after serious ICU illnesses like sepsis, major trauma, or open heart/abdominal surgery. It may help researchers understand why recovery can be harder in some people and guide future treatments.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.